Saturday, July 11, 2026

pharma · Gout

LG Chem

LG Chem is a pharma organization headquartered in CN. Primary therapeutic focus areas include Gout. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EM

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
1
Patents
0
Clinical program

Tigulixostat

Phase 3 · small molecule · Gout

Tigulixostat for Gout is a Phase 3 program (small_molecule) at LG Chem with 2 ClinicalTrials.gov record(s).

← All LG Chem projects Phase 3 small molecule completed

Internal code LG-GDCL009

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
LG Chem
Phase
Phase 3
Modality
small_molecule
Indication
Gout
Status
completed
Trials
2